Phase IIa Clinical Study of a New Human Neutrophil Elastase Inhibitor, EPI-hNE4 (DX890), with repeated Administration by Inhalation in Adult CF Patients November 25, 2003 A. Labbé, I. Durieu,; B. Wallaert; H. Sayah; B. Assael; G. Cazzola, C. Dubra, A. Poncin, C. Lafuma, T. Williams, A. Bokman*, H. Clavien*, F. Saudubray* * Debiopharm
